Legend Biotech Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 165.65, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Legend Biotech in Dec 31 2025 quarter, has decreased to 2 days, compared to 4 days, in the 0 quarter.

If we take a look into Healthcare sector 62 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 630.

What is Receivable Turnover Ratio?
What is Legend Biotech Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LEGN Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	104.69 %	75.32 %	111.15 %	-88.84 %	-93.6 %
Y / Y Revenue Change	451.62 %	69.99 %	36.74 %	107.52 %	-34.59 %
Receivable Turnover Ratio (TTM)	165.65	102.16	90.92	141.84	106.87
LEGN's Total Ranking	# 630	# 0	#	#	#
Accounts Receivable average collection period days	2	4	4	3	3
Seq. Receivable Change	959.87 %	-95.52 %	7375.34 %	-94.23 %	807.8 %
Seq. Revenue Change	277.81 %	6.77 %	30.76 %	4.57 %	16.43 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 24
Healthcare Sector	# 63
Overall Market	# 630

Receivable Turnover Ratio Statistics
High	Average	Low
24.21	8.82	0.99
(Dec 31 2025)		(Dec 31 2020)

LEGN Company Profile • Back to LEGN Efficiency Comparisons • Compare LEGN Receivables Turnover Ratio to its Competitors

Financial Statements
Legend Biotech's Accounts Receivable	$ 13 Millions	Visit LEGN's Balance sheet
Legend Biotech's Sales TTM	$ 1,751 Millions	Visit LEGN's Income Statement
Sources of LEGN's Revenues		Visit LEGN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LEGN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
LEGN's Growth Rates	LEGN's Roa	LEGN's Inventory Turnover Ratio	LEGN's Dividend Comparisons
LEGN's Profitability Ratios	LEGN's Roi	LEGN's Asset Turnover Ratio	LEGN's Dividend Growth
LEGN's Valuation Ratios	LEGN's Roe	LEGN's Financial Strength Ratios	LEGN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Bausch Health Companies Inc	348.00	$ 10,266.000 Millions	$ 29.500 Millions
Nakamoto Inc	345.50	$ 1.821 Millions	$ 0.005 Millions
Medicure Inc	264.72	$ 22.103 Millions	$ 0.083 Millions
Ginkgo Bioworks Holdings Inc	226.19	$ 170.155 Millions	$ 0.752 Millions
Fortress Biotech Inc	216.84	$ 63.262 Millions	$ 0.292 Millions
Zeo Scientifix Inc	200.18	$ 5.555 Millions	$ 0.028 Millions
Arcus Biosciences Inc	197.60	$ 247.000 Millions	$ 1.250 Millions
Immunocore Holdings Plc	181.15	$ 400.016 Millions	$ 2.208 Millions
Arrowhead Pharmaceuticals Inc	169.72	$ 1,090.981 Millions	$ 6.428 Millions
Earth Science Tech Inc	159.09	$ 32.891 Millions	$ 0.207 Millions
Assembly Biosciences Inc	153.35	$ 72.303 Millions	$ 0.472 Millions
Koninklijke Philips Nv	149.87	$ 19,974.080 Millions	$ 133.280 Millions
Prime Medicine Inc	135.24	$ 4.632 Millions	$ 0.034 Millions
Bridgebio Oncology Therapeutics Inc	117.58	$ 11.347 Millions	$ 0.097 Millions
Logicmark Inc	114.88	$ 11.426 Millions	$ 0.099 Millions
Harvard Apparatus Regenerative Technology Inc	100.57	$ 0.704 Millions	$ 0.007 Millions
Mangoceuticals Inc	90.95	$ 0.456 Millions	$ 0.005 Millions
Sbc Medical Group Holdings Incorporated	76.66	$ 171.922 Millions	$ 2.243 Millions
Aclaris Therapeutics Inc	70.50	$ 7.826 Millions	$ 0.111 Millions
Agape Atp Corporation	70.27	$ 1.524 Millions	$ 0.022 Millions
Humacyte Inc	67.98	$ 40.803 Millions	$ 0.600 Millions
Airsculpt Technologies Inc	59.97	$ 151.818 Millions	$ 2.532 Millions
Spero Therapeutics Inc	56.29	$ 66.802 Millions	$ 1.187 Millions
Crinetics Pharmaceuticals Inc	52.00	$ 7.696 Millions	$ 0.148 Millions
Brookdale Senior Living Inc	51.27	$ 3,194.066 Millions	$ 62.298 Millions
Eyepoint Inc	45.42	$ 31.371 Millions	$ 0.691 Millions
X4 Pharmaceuticals Inc	45.05	$ 35.113 Millions	$ 0.780 Millions
Fortrea Holdings Inc	44.55	$ 2,723.400 Millions	$ 61.125 Millions
Longduoduo Co Ltd	44.55	$ 2.722 Millions	$ 0.061 Millions
Lifevantage Corp	44.29	$ 208.401 Millions	$ 4.705 Millions

Date modified: 2026-09-05T14:48:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.